Tag - biopharmaceuticals

Developments

iBio expands collaboration with AzarGen to develop plant-made rituximab

iBio (NYSE AMERICAN:IBIO) advanced its collaboration with closely-held AzarGen Biotechnologies by initiating development of a plant-made rituximab for the South African market. iBio previously used its FastPharming...

September 17, 2019

Developments

iBio and CC-Pharming expand biopharma business collaboration in China

iBio (NYSE AMERICAN:IBIO) granted partner CC-Pharming an exclusive, royalty-bearing commercial license to iBio’s bio-better rituximab product candidates in China.

August 27, 2019

Tag - biopharmaceuticals

iBio expands collaboration with AzarGen to develop plant-made rituximab

iBio and CC-Pharming expand biopharma business collaboration in China

General

More